GENEREX BIOTECHNOLOGY

Serial Number 76176126
606

Registration Progress

Application Filed
Dec 5, 2000
Under Examination
Oct 12, 2004
Approved for Publication
Dec 17, 2003
Published for Opposition
Jan 6, 2004
Registered

Trademark Image

GENEREX BIOTECHNOLOGY

Basic Information

Serial Number
76176126
Filing Date
December 5, 2000
Published for Opposition
January 6, 2004
Abandonment Date
October 15, 2007
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 15, 2007
Classes
005

Rights Holder

GENEREX PHARMACEUTICALS INC.

03
Address
33 HARBOUR SQUARE, SUITE 202
TORONTO, ONTARIO M5J 2G2
CA

Ownership History

Generex Biotechnology Corporation

Original Applicant
03
Toronto Ontario CA

Generex Biotechnology Corporation

Owner at Publication
03
Toronto Ontario CA

GENEREX PHARMACEUTICALS INC.

New Owner After Publication #1
03
TORONTO, ONTARIO CA

Legal Representation

Attorney
John L. DuPre

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

37 events
Date Code Type Description Documents
Jan 22, 2008 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 22, 2008 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jul 28, 2007 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 6, 2007 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 13, 2007 MAIL I PAPER RECEIVED Loading...
Apr 12, 2007 EXT5 S SOU EXTENSION 5 FILED Loading...
Feb 15, 2007 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 2, 2006 MAIL I PAPER RECEIVED Loading...
Oct 2, 2006 EXT4 S SOU EXTENSION 4 FILED Loading...
May 4, 2006 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 18, 2006 MAIL I PAPER RECEIVED Loading...
Apr 12, 2006 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 15, 2005 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 30, 2005 MAIL I PAPER RECEIVED Loading...
Sep 30, 2005 EXT2 S SOU EXTENSION 2 FILED Loading...
May 3, 2005 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 7, 2005 MAIL I PAPER RECEIVED Loading...
Apr 7, 2005 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 23, 2004 MAIL I PAPER RECEIVED Loading...
Oct 12, 2004 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 18, 2004 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Feb 4, 2004 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jan 6, 2004 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 17, 2003 NPUB O NOTICE OF PUBLICATION Loading...
Nov 14, 2003 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 10, 2003 REIN O REINSTATED Loading...
Jun 25, 2003 MAIL I PAPER RECEIVED Loading...
Jun 13, 2003 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Oct 10, 2002 CNRT O NON-FINAL ACTION MAILED Loading...
Oct 8, 2002 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 17, 2002 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 13, 2002 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 13, 2001 CNRT O NON-FINAL ACTION MAILED Loading...
Nov 1, 2001 CNEA O EXAMINERS AMENDMENT MAILED Loading...
May 17, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 5, 2001 CNRT F NON-FINAL ACTION MAILED Loading...
Mar 30, 2001 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations administerable through mucous membranes for the treatment of diabetes, prostate cancer, endometriosis, breakthrough cancer pain, and for use in providing anticoagulant therapy in the treatment of heart disease
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOTECHNOLOGY"